Boston, San Francisco, and a few other metro areas might dominate the US life sciences, but some weeks, all bio-related eyes are on the nation’s capital. Health concerns about vaping continue to mount, and the feds could get involved. Meanwhile, try to find someone in the federal government who isn’t involved in the drug-price debate. OK, that’s a rhetorical flourish—we are talking about politics, after all—but with the debut of the House drug-price legislation this week, there are now plans of various stripes in both houses of Congress and the White House.
There was plenty of news beyond the Beltway, from… Read more »
UNDERWRITERS AND PARTNERS
